ConductScience.org, home

Paper41674841

Concurrent Germline-Somatic Alterations and Associations with Cancer Outcomes: A Systematic Review of Concurrent Data Use.

Pal LR and 5 others. Res Sq, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Concurrent Germline-Somatic Alterations and Associations with Cancer Outcomes: A Systematic Review of Concurrent Data Use. Papers, record 41674841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41674841

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Concurrent Germline-Somatic Alterations and Associations with Cancer Outcomes: A Systematic Review of Concurrent Data Use.
PubMed
Journal
Res Sq
PubMed
Year
2026
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pal LRLipika R
2Schäffer AAAlejandro A
3Avila SSantiago
4Wooten JJonathan
5Butera GGisela
6Rajagopal PSPadma Sheila

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIA BC012112Intramural NIH HHSUnited StatesZIABC012112PubMed

Source NIH RePORTER

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138815010Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity.Science2024https://conductscience.org/library/papers/38815010PubMed
234664259The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies.Clin Pharmacol Ther2022https://conductscience.org/library/papers/34664259PubMed
327167109A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.Oncotarget2016https://conductscience.org/library/papers/27167109PubMed
428428277Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer.Cancer Res2017https://conductscience.org/library/papers/28428277PubMed
528188128Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.Cancer Discov2017https://conductscience.org/library/papers/28188128PubMed
635764656The impact of rare germline variants on human somatic mutation processes.Nat Commun2022https://conductscience.org/library/papers/35764656PubMed
732336025Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments.Res Synth Methods2021https://conductscience.org/library/papers/32336025PubMed
838908000When the somatic genome informs the germline: the example of TP53.J Natl Cancer Inst2024https://conductscience.org/library/papers/38908000PubMed
936860655Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.Cancer Res Commun2023https://conductscience.org/library/papers/36860655PubMed
1037992259
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature.
JCO Precis Oncol2023https://conductscience.org/library/papers/37992259PubMed
1122522925The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.Nature2012https://conductscience.org/library/papers/22522925PubMed
1237963304Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.J Clin Oncol2024https://conductscience.org/library/papers/37963304PubMed
1333268447Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations.Cancer Discov2021https://conductscience.org/library/papers/33268447PubMed
1430596875PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.Ann Intern Med2019https://conductscience.org/library/papers/30596875PubMed
1528916367Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet2017https://conductscience.org/library/papers/28916367PubMed
1639629784Clinicopathologic Features of Breast Tumors in Germline TP53 Variant-Associated Li-Fraumeni Syndrome.Am J Surg Pathol2025https://conductscience.org/library/papers/39629784PubMed
1728783718Integrative clinical genomics of metastatic cancer.Nature2017https://conductscience.org/library/papers/28783718PubMed
1827161491The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.Nat Commun2016https://conductscience.org/library/papers/27161491PubMed
19185402Developmental genetics of neuroblastoma.J Natl Cancer Inst1976https://conductscience.org/library/papers/185402PubMed
2035090043Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.Cancer2022https://conductscience.org/library/papers/35090043PubMed

See all 30 referencesDownload CSV of references

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41674841

GET https://conductscience.org/api/papers/v1/41674841/references?page=2